Synthesis of Linear, β-Cyclodextrin-Based Polymers and Their Camptothecin Conjugates
- 27 August 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 14 (5) , 1007-1017
- https://doi.org/10.1021/bc0340924
Abstract
6A,6D-Bis-(2-amino-2-carboxylethylthio)-6A,6D-dideoxy-β-cyclodextrin 1, a diamino acid derivative of β-cyclodextrin, is synthesized and condensed with difunctionalized PEG comonomers to give linear, high molecular weight (Mw over 50 kDa) β-cyclodextrin-based polymers (2−4) with pendant functionality (carboxylate). 2−4 are all highly soluble in aqueous solutions (over 200 mg/mL). 20-O-trifluoroglycinylcamptothecin, 5a, and 20-O-trifluoroglycinylglycinylglycinylcamptothecin, 5b, are synthesized and conjugated to 2 to give polymer−camptothecin (CPT) prodrugs. The solubility of CPT is increased by more than three orders of magnitude when it is conjugated to 2. The rates of CPT release from the conjugates HGGG6 (high molecular weight polymer (Mw 97 kDa), glyglygly linker and 6 wt % CPT loading) and HG6 (high MW polymer (Mw 97 kDa), gly linker and 6 wt % CPT loading) in either mouse or human plasma are dramatically accelerated over the rates of pure hydrolysis at pH = 7.4, indicating the presence of enzymatic cleavage as a rate-determining step at this pH in the release of the CPT. The pH of aqueous solution has a large effect on hydrolysis rate of CPT from HGGG6 and HG6; the lower the pH, the slower the rate in the range at 4.1 ≤ pH ≤ 13.1. The IC50's of polymer 2e, CPT, and the CPT conjugates HG6 and HGGG6 are found to be cell-line dependent with LS174T, HT29, A2780, and PC3 cells using in vitro MTT assays. The parent polymer 2e has very low toxicity to all cultured cells tested.Keywords
This publication has 9 references indexed in Scilit:
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- A Phase I and Pharmacokinetic Study of Pegylated Camptothecin as a 1-Hour Infusion Every 3 Weeks in Patients With Advanced Solid MalignanciesJournal of Clinical Oncology, 2003
- Analysis of CUL-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissuesMolecular Cancer, 2003
- Synthesis and in Vivo Antitumor Activity of Poly(l-glutamic acid) Conjugates of 20(S)-CamptothecinJournal of Medicinal Chemistry, 2002
- Polymer–drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinicJournal of Controlled Release, 2001
- Water-soluble poly-(l-glutamic acid)–Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivoJournal of Controlled Release, 2001
- Polymer-bound camptothecin: initial biodistribution and antitumour activity studiesJournal of Controlled Release, 2000
- Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)European Journal Of Cancer, 1999
- Cyclodextrin Drug Carrier SystemsChemical Reviews, 1998